Revenue: The sum of all revenue fields included for a company's operating activities.
Catalyst Pharmaceuticals, Inc. (CPRX) had Revenue of $141.42M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$141.42M |
$56.74M |
|
$17.91M |
|
$123.51M |
|
$78.05M |
|
$63.37M |
|
$7.92M |
|
$71.29M |
|
$71.29M |
|
$56.74M |
|
$56.74M |
|
$56.74M |
|
$56.74M |
|
$63.37M |
|
$72.83M |
|
121.47M |
|
126.96M |
|
$0.47 |
|
$0.45 |
|
| Balance Sheet Financials | |
$685.72M |
|
$1.24M |
|
$223.15M |
|
$908.87M |
|
$111.65M |
|
-- |
|
$2.94M |
|
$114.59M |
|
$794.28M |
|
$646.96M |
|
$794.28M |
|
121.96M |
|
| Cash Flow Statement Financials | |
$60.04M |
|
$0.00M |
|
$3.06M |
|
$517.55M |
|
$580.66M |
|
$63.10M |
|
$5.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.33% |
|
44.81% |
|
44.81% |
|
-- |
|
50.41% |
|
40.12% |
|
$60.04M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.91 |
|
1.98 |
|
45.35 |
|
7.14% |
|
8.77% |
|
6.24% |
|
7.14% |
|
$6.51 |
|
$0.47 |
|
$0.47 |
|